Trials / Sponsors / Curium US LLC
Curium US LLC
Industry · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer Prostate Cancer, Prostate Adenocarcinoma, Biochemical Recurrence of Malignant Neoplasm of Prostate | Phase 3 | 2024-04-01 |
| Recruiting | Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer Prostate Cancer, Prostate Adenocarcinoma | Phase 3 | 2024-04-01 |
| Completed | Cu-64-PSMA-I&T Positron Emission Tomography (PET) Imaging of Metastatic PSMA Positive Lesions in Men With Pros Metastasis From Malignant Tumor of Prostate (Disorder) | Phase 2 | 2022-12-05 |
| Active Not Recruiting | 177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer Metastasis From Malignant Tumor of Prostate | Phase 3 | 2022-02-14 |
| Approved For Marketing | Copper Cu 64 Dotatate for the Detection, Localization and Monitoring of SSTR Expressing (NETs) Neuroendocrine Tumors | — | — |